727 related articles for article (PubMed ID: 25562266)
1. Quadrivalent HPV vaccination and risk of multiple sclerosis and other demyelinating diseases of the central nervous system.
Scheller NM; Svanström H; Pasternak B; Arnheim-Dahlström L; Sundström K; Fink K; Hviid A
JAMA; 2015 Jan; 313(1):54-61. PubMed ID: 25562266
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus vaccination of adult women and risk of autoimmune and neurological diseases.
Hviid A; Svanström H; Scheller NM; Grönlund O; Pasternak B; Arnheim-Dahlström L
J Intern Med; 2018 Feb; 283(2):154-165. PubMed ID: 29044769
[TBL] [Abstract][Full Text] [Related]
3. Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma.
Herweijer E; Leval A; Ploner A; Eloranta S; Simard JF; Dillner J; Netterlid E; Sparén P; Arnheim-Dahlström L
JAMA; 2014 Feb; 311(6):597-603. PubMed ID: 24519299
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study.
Arnheim-Dahlström L; Pasternak B; Svanström H; Sparén P; Hviid A
BMJ; 2013 Oct; 347():f5906. PubMed ID: 24108159
[TBL] [Abstract][Full Text] [Related]
5. Quadrivalent human papillomavirus vaccination in boys and risk of autoimmune diseases, neurological diseases and venous thromboembolism.
Frisch M; Besson A; Clemmensen KKB; Valentiner-Branth P; Mølbak K; Hviid A
Int J Epidemiol; 2018 Apr; 47(2):634-641. PubMed ID: 29425361
[TBL] [Abstract][Full Text] [Related]
6. Incidence of new-onset autoimmune disease in girls and women with pre-existing autoimmune disease after quadrivalent human papillomavirus vaccination: a cohort study.
Grönlund O; Herweijer E; Sundström K; Arnheim-Dahlström L
J Intern Med; 2016 Dec; 280(6):618-626. PubMed ID: 27478093
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study.
Dominiak-Felden G; Gobbo C; Simondon F
PLoS One; 2015; 10(7):e0132404. PubMed ID: 26147096
[TBL] [Abstract][Full Text] [Related]
8. Timing of two versus three doses of quadrivalent HPV vaccine and associated effectiveness against condyloma in Sweden: a nationwide cohort study.
Lamb F; Herweijer E; Ploner A; Uhnoo I; Sundström K; Sparén P; Arnheim-Dahlström L
BMJ Open; 2017 Jun; 7(6):e015021. PubMed ID: 28600369
[TBL] [Abstract][Full Text] [Related]
9. CNS demyelination and quadrivalent HPV vaccination.
Sutton I; Lahoria R; Tan I; Clouston P; Barnett M
Mult Scler; 2009 Jan; 15(1):116-9. PubMed ID: 18805844
[TBL] [Abstract][Full Text] [Related]
10. ACP Journal Club: quadrivalent HPV vaccination was not linked to multiple sclerosis or other demyelinating diseases.
Granwehr B
Ann Intern Med; 2015 Apr; 162(8):JC13. PubMed ID: 25894046
[No Abstract] [Full Text] [Related]
11. Association between human papillomavirus vaccination and serious adverse events in South Korean adolescent girls: nationwide cohort study.
Yoon D; Lee JH; Lee H; Shin JY
BMJ; 2021 Jan; 372():m4931. PubMed ID: 33514507
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects.
Grimaldi-Bensouda L; Guillemot D; Godeau B; Bénichou J; Lebrun-Frenay C; Papeix C; Labauge P; Berquin P; Penfornis A; Benhamou PY; Nicolino M; Simon A; Viallard JF; Costedoat-Chalumeau N; Courcoux MF; Pondarré C; Hilliquin P; Chatelus E; Foltz V; Guillaume S; Rossignol M; Abenhaim L;
J Intern Med; 2014 Apr; 275(4):398-408. PubMed ID: 24206418
[TBL] [Abstract][Full Text] [Related]
13. The impact of HPV multi-cohort vaccination: Real-world evidence of faster control of HPV-related morbidity.
Orumaa M; Kjaer SK; Dehlendorff C; Munk C; Olsen AO; Hansen BT; Campbell S; Nygård M
Vaccine; 2020 Feb; 38(6):1345-1351. PubMed ID: 31917039
[TBL] [Abstract][Full Text] [Related]
14. Association between quadrivalent human papillomavirus vaccination and selected syndromes with autonomic dysfunction in Danish females: population based, self-controlled, case series analysis.
Hviid A; Thorsen NM; Valentiner-Branth P; Frisch M; Mølbak K
BMJ; 2020 Sep; 370():m2930. PubMed ID: 32878745
[TBL] [Abstract][Full Text] [Related]
15. The human papillomavirus vaccination is not associated with risk of multiple sclerosis or other demyelinating diseases.
Perkins RB; Christiansen CL
Evid Based Med; 2015 Jun; 20(3):116. PubMed ID: 25841246
[No Abstract] [Full Text] [Related]
16. The Efficacy of the Quadrivalent Human Papillomavirus Vaccine in Girls and Women Living With Human Immunodeficiency Virus.
McClymont E; Lee M; Raboud J; Coutlée F; Walmsley S; Lipsky N; Loutfy M; Trottier S; Smaill F; Klein MB; Harris M; Cohen J; Yudin MH; Wobeser W; Money D;
Clin Infect Dis; 2019 Feb; 68(5):788-794. PubMed ID: 29985988
[TBL] [Abstract][Full Text] [Related]
17. Vaccines and the risk of multiple sclerosis and other central nervous system demyelinating diseases.
Langer-Gould A; Qian L; Tartof SY; Brara SM; Jacobsen SJ; Beaber BE; Sy LS; Chao C; Hechter R; Tseng HF
JAMA Neurol; 2014 Dec; 71(12):1506-13. PubMed ID: 25329096
[TBL] [Abstract][Full Text] [Related]
18. Association Between Human Papillomavirus Vaccination and Primary Ovarian Insufficiency in a Nationwide Cohort.
Hviid A; Myrup Thiesson E
JAMA Netw Open; 2021 Aug; 4(8):e2120391. PubMed ID: 34436612
[TBL] [Abstract][Full Text] [Related]
19. Prevention of recurrent high-grade anal neoplasia with quadrivalent human papillomavirus vaccination of men who have sex with men: a nonconcurrent cohort study.
Swedish KA; Factor SH; Goldstone SE
Clin Infect Dis; 2012 Apr; 54(7):891-8. PubMed ID: 22291111
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of varying number of doses and timing between doses of quadrivalent HPV vaccine against severe cervical lesions.
Dehlendorff C; Sparén P; Baldur-Felskov B; Herweijer E; Arnheim-Dahlström L; Ploner A; Uhnoo I; Kjaer SK
Vaccine; 2018 Oct; 36(43):6373-6378. PubMed ID: 30249423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]